ASX announcements
COVID_19 Impact
23 March 2020
Virtus Health Limited (ASX “VRT”) provides the following statement on the current impact of COVID-19.
Virtus Appoints Kate Munnings to Board of Directors
19 March 2020
Virtus Health ASX announcement - Virtus Appoints Kate Munnings to Board of Directors
Virtus Health financial results presentation H1 FY20
18 February 2020
Virtus Health financial results presentation H1 FY20
Appointment of New Group Chief Executive Officer
24 January 2020
Appointment of New Group Chief Executive Officer ASX announcement
Virtus Health Acquisition of SIMS IVF Shares
11 December 2019
Virtus Health Acquisition of SIMS IVF Shares
Notice of Annual General Meeting and Proxy Form
16 October 2019
Notice of Annual General Meeting and Proxy Form
Virtus appoints Dr Michael Stanford AM to Board of Directors - 4 September 2019
4 September 2019
Virtus appoints Dr Michael Stanford AM to Board of Directors - 4 September 2019
Appendix 4E Preliminary Final Report - 30 June 2019
20 August 2019
Appendix 4E Preliminary Final Report - 30 June 2019
Virtus Health Full Year Financial Results FY2019 media release
20 August 2019
Virtus Health Full Year Financial Results FY2019 media release
Notification of FY19 full year results - reporting date and investor conference call
13 August 2019
Notification of FY19 full year results - reporting date and investor conference call
Notification of Release of Restricted Shares from Escrow
2 August 2019
Notification of Release of Restricted Shares from Escrow
Entry into transfer and collaboration agreements for AI
10 April 2019
Entry into transfer and collaboration agreements for AI
Notification of Dividend Distribution H1 FY2019
19 February 2019
Notification of Dividend Distribution H1 FY2019